Carna Biosciences (TSE:4572) Other Net Income (Loss) : 円-0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Other Net Income (Loss)?

Carna Biosciences's Other Net Income (Loss) for the three months ended in Mar. 2024 was 円-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was 円-0 Mil.

Carna Biosciences's quarterly Other Net Income (Loss) declined from Sep. 2023 (円0 Mil) to Dec. 2023 (円-0 Mil) and declined from Dec. 2023 (円-0 Mil) to Mar. 2024 (円-0 Mil).

Carna Biosciences's annual Other Net Income (Loss) stayed the same from Dec. 2021 (円0 Mil) to Dec. 2022 (円0 Mil) but then declined from Dec. 2022 (円0 Mil) to Dec. 2023 (円-0 Mil).

Carna Biosciences Other Net Income (Loss) Historical Data

The historical data trend for Carna Biosciences's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Other Net Income (Loss) Chart

Carna Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Carna Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Carna Biosciences Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-0 Mil.

Carna Biosciences Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences (TSE:4572) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines